Senseonics Announces CE Mark Approval Of The Eversense CGM System

Senseonics Holdings, Inc., a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring (CGM) system for people with diabetes, recently announced it has received CE Mark approval for the EversenseContinuous Glucose Monitoring (CGM) System.
Source: Medical Design Online News - Category: Medical Equipment Source Type: news